Geldanamycin

Revision as of 19:02, 27 September 2011 by WikiBot (talk | contribs) (Protected "Geldanamycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Chembox new

WikiDoc Resources for Geldanamycin

Articles

Most recent articles on Geldanamycin

Most cited articles on Geldanamycin

Review articles on Geldanamycin

Articles on Geldanamycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Geldanamycin

Images of Geldanamycin

Photos of Geldanamycin

Podcasts & MP3s on Geldanamycin

Videos on Geldanamycin

Evidence Based Medicine

Cochrane Collaboration on Geldanamycin

Bandolier on Geldanamycin

TRIP on Geldanamycin

Clinical Trials

Ongoing Trials on Geldanamycin at Clinical Trials.gov

Trial results on Geldanamycin

Clinical Trials on Geldanamycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Geldanamycin

NICE Guidance on Geldanamycin

NHS PRODIGY Guidance

FDA on Geldanamycin

CDC on Geldanamycin

Books

Books on Geldanamycin

News

Geldanamycin in the news

Be alerted to news on Geldanamycin

News trends on Geldanamycin

Commentary

Blogs on Geldanamycin

Definitions

Definitions of Geldanamycin

Patient Resources / Community

Patient resources on Geldanamycin

Discussion groups on Geldanamycin

Patient Handouts on Geldanamycin

Directions to Hospitals Treating Geldanamycin

Risk calculators and risk factors for Geldanamycin

Healthcare Provider Resources

Symptoms of Geldanamycin

Causes & Risk Factors for Geldanamycin

Diagnostic studies for Geldanamycin

Treatment of Geldanamycin

Continuing Medical Education (CME)

CME Programs on Geldanamycin

International

Geldanamycin en Espanol

Geldanamycin en Francais

Business

Geldanamycin in the Marketplace

Patents on Geldanamycin

Experimental / Informatics

List of terms related to Geldanamycin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Geldanamycin is a benzoquinone ansamycin antibiotic that binds to Hsp90 (Heat Shock Protein 90) and alters its function. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis.

Geldanamycin induces the degradation of proteins that are mutated in tumor cells such as v-Src, Bcr-Abl and p53 preferentially over their normal cellular counterparts. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate (namely, hepatotoxicity) that have led to the development of geldanamycin analogues, in particular analogues containing a derivatisation at the 17 position:

17-AAG

17-DMAG

References

  • Bedin M, Gaben AM, Saucier C, Mester J. Int J Cancer. 2004 May 1;109(5):643-52. Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.

External links

Template:SIB

de:Geldanamycin


Template:WikiDoc Sources